Literature DB >> 12169829

Angiotensin-converting enzyme gene insertion/deletion polymorphism in Kuwaiti children with retinopathy of prematurity.

M Z Haider1, L V Devarajan, M Al-Essa, H Kumar.   

Abstract

Retinopathy of prematurity (ROP) is a disease characterized by neovascularization which occurs in infants with short gestational age and low birth weight and can lead to retinal detachment and blindness. In a proportion of ROP cases, the disease progresses to advanced stages despite rigorous intervention. The genotypes for angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism were determined in 181 premature Kuwaiti infants using a polymerase chain reaction (PCR) method. The incidence of different I/D genotypes was compared in ROP cases (n = 74) and non-ROP controls (n = 107) and within 2 subgroups of ROP patients: (1) in which ROP regressed spontaneously (stages 1-3, n = 53), and (2) in which ROP progressed to advanced stages (stages 4 and 5, n = 21). When the ROP cases were considered collectively as one group, the incidence of the DD genotype was almost identical to that of non-ROP controls. The incidence of heterozygous ID genotype was higher in non-ROP controls. The incidence of the II genotype was higher in ROP cases compared to non-ROP controls (p < 0.01). In contrast to this, when ROP cases were divided in 2 subgroups the incidence of the DD genotype was significantly higher in advanced stage ROP cases compared to spontaneously regressing ROP cases (p < 0.04). The incidences of ID and II genotypes were not significantly different amongst the 2 subgroups of ROP patients. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12169829     DOI: 10.1159/000063092

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  7 in total

Review 1.  Impact of common genetic variation on neonatal disease and outcome.

Authors:  David Harding
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-09       Impact factor: 5.747

2.  Influence of polymorphisms in VEGF, ACE, TNF and GST genes on the susceptibility to retinopathy of prematurity among Chinese infants.

Authors:  Xiao-Jun Lei; Yong-Xia Zhao; Tong Qiao
Journal:  Int J Ophthalmol       Date:  2018-09-18       Impact factor: 1.779

Review 3.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

Review 4.  Retinopathy of prematurity: contribution of inflammatory and genetic factors.

Authors:  Mariza Fevereiro-Martins; Hercília Guimarães; Carlos Marques-Neves; Manuel Bicho
Journal:  Mol Cell Biochem       Date:  2022-03-09       Impact factor: 3.396

Review 5.  Genetic susceptibility to advanced retinopathy of prematurity (ROP).

Authors:  Barkur S Shastry
Journal:  J Biomed Sci       Date:  2010-08-25       Impact factor: 8.410

6.  Genetic Contributions to the Development of Complications in Preterm Newborns.

Authors:  Chiara Poggi; Betti Giusti; Elena Gozzini; Alice Sereni; Ilaria Romagnuolo; Ada Kura; Elisabetta Pasquini; Rosanna Abbate; Carlo Dani
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

7.  The genetics of retinopathy of prematurity: a model for neovascular retinal disease.

Authors:  Ryan Swan; Sang Jin Kim; J Peter Campbell; R V Paul Chan; Kemal Sonmez; Kent D Taylor; Xiaohui Li; Yii-Der Ida Chen; Jerome I Rotter; Charles Simmons; Michael F Chiang
Journal:  Ophthalmol Retina       Date:  2018-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.